FDA OKs New Therapy for Some Hemophilia Patients - NBC Chicago
National & International News
The day’s top national and international news

FDA OKs New Therapy for Some Hemophilia Patients

Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that

    processing...

    NEWSLETTERS

    Spend Memorial Day Weekend at The St. Charles Fine Art Show
    AP/Genentech, Inc.
    This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder.

    The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection for hemophilia A patients who have developed resistance to standard medicines.

    Genentech, the drug's developer, says the list price will be about $482,000 for the first year and slightly less after that.

    Genentech, a subsidiary of Swiss drugmaker Roche, says that's half the cost of the only other option for patients with this resistance. That treatment requires an IV drip several times a week.

    Weinstein Charged With Rape in Historic #MeToo Moment

    [NATL] Harvey Weinstein Charged With Rape, Leaves in Cuffs in Historic #MeToo Moment

    Disgraced movie mogul Harvey Weinstein surrendered to police in a watershed moment for the #MeToo movement early Friday morning. Weinstein was charged with rape, criminal sex act and other sex crimes connected to cases involving two separate women.

    (Published Friday, May 25, 2018)

    Hemophilia mostly affects males.